No image

Diazyme

Details

Device type1,5-Anhydroglucitol IVD, control: A material which is used to verify the performance of an assay intended to be used for the quantitative measurement of 1,5-anhydroglucitol in a clinical specimen.

FDA categoryAssay, 1,5-Anhydroglucitol (15ag)

Device ID00817089022539

AvailabilityPrescription

MRI safetyLabeling does not contain MRI Safety Information

Contact

No contact is listed for this device.

Related products

Product	Model	Company	Device type
DiazymeDiazyme Laboratories, Inc.Glycated albumin IVD, reagent	DZ112B-SMA	Diazyme Laboratories, Inc.	Glycated albumin IVD, reagent
LiquichekBio-Rad Laboratories, Inc.Glycated haemoglobin (HbA1c) IVD, control	172	Bio-Rad Laboratories, Inc.	Glycated haemoglobin (HbA1c) IVD, control
Trinity BiotechClark Laboratories, Inc.Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, control	G5888	Clark Laboratories, Inc.	Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, control
Research and Diagnostic SystemsResearch and Diagnostic Systems, Inc.Glucose/haemoglobin (Hb) IVD, control	GH00NX	Research and Diagnostic Systems, Inc.	Glucose/haemoglobin (Hb) IVD, control